Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshitaka YAMAZAKI
The Synergistic Antitumor Effect of Combined Anti-Human Epidermal Growth Factor Receptor 2 Antibody and Gamma Interferon Therapy on Antibody-Resistant Breast Cancer Cells
The Showa University Journal of Medical Sciences
Pulmonary Sarcoidosis With Associated Bloody Pleurisy.
Internal Medicine
Internal Medicine
Medicine
Related publications
Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
Frontiers in Immunology
Allergy
Immunology
Effect of Combining Anti-Epidermal Growth Factor Receptor Antibody C225 and Radiation on DU145 Prostate Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2
Cancer Research
Cancer Research
Oncology
Expression of Growth Factor Receptor Family Before and After Targeted Therapy in Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Tissues
Korean Journal of Clinical Oncology
Association Between Serum Ligands and the Skin Toxicity of Anti-Epidermal Growth Factor Receptor Antibody in Metastatic Colorectal Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Synergistic Antitumor Activity of Sorafenib in Combination With Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Pertuzumab in Human Epidermal Growth-Factor Receptor 2-Positive Breast Cancer: Clinical and Economic Considerations
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics
Impact of Clinicopathological Characteristics on the Efficacy of Neoadjuvant Therapy in Patients With Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
International Journal of Cancer
Cancer Research
Oncology